logo
logo
Sign in

Nicotine Replacement Therapy Market 2021 Size & Share | Market worth USD 3.54 billion with 4.2% CAGR by 2027

avatar
saurabh jadhav
Nicotine Replacement Therapy Market 2021 Size & Share | Market worth USD 3.54 billion with 4.2% CAGR by 2027

The global “Nicotine Replacement Therapy Market” is expected to gain momentum by exhibiting a CAGR of 4.2% between 2020 and 2027. This is attributable to increasing incidence of chronic disease such as lung cancer, strokes, and respiratory ailments. Additionally, introduction of innovative products by major companies will favor market growth. This information is published by Fortune Business Insights, in its latest report, titled, “Nicotine Replacement Therapy (NRT) Market Size, Share &COVID-19 Impact Analysis, By Type (Gums, Patches, Lozenges, Inhalers, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.”The report further observes that the market was valued at USD 2.55 billion in 2019 and is projected to reach USD 3.54 billion by 2027.

Major Nicotine Replacement Therapy Market Key players covered in the report include:

  • GlaxoSmithKline plc (U.K, Europe)
  • Johnson & Johnson Inc (New Jersey, U.S)
  • Perrigo Company plc (Ireland, Europe)
  • Pierre Fabre SA, Laboratories (France, Europe)
  • Pfizer Inc. (New York, United States)
  • Cipla Limited (Mumbai, India)
  • British American Tobacco Plc (U.K, Europe)
  • Other Players

Get Sample Report Of Nicotine Replacement Therapy Market Report at:

https://www.fortunebusinessinsights.com/enquiry/sample/nicotine-replacement-therapy-nrt-market-103362

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Nicotine Replacement Therapy Market Analysis 2021:

Draving Factors :

Increasing Incidence of Chronic Disease to Bolster Growth

According to the Center for Disease Control and Prevention (CDC), smoking cigarettes leads to over 80% to 90% of lung cancer deaths every year in the United States. Tobacco smoke consists of over 7000 chemicals, with over 70 chemicals known to cause cancer in humans. Furthermore, the increasing incidence of chronic ailments is propelling the major companies to introduce innovative nicotine replacement therapy products that aid in to curb the urge to smoke in the people. The growing tobacco addiction in the youth is further driving the demand for the NTR products that will bode well for the growth of the global nicotine replacement therapy market during the forecast period.

 

For more information visit : https://www.fortunebusinessinsights.com/nicotine-replacement-therapy-nrt-market-103362

collect
0
avatar
saurabh jadhav
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more